Cardiac actin is an early marker of cardiac and skeletal muscle lineages in the mouse. After birth, the gene is downregulated in skeletal muscle. High-level expression of the murine cardiac actin gene in skeletal myotubes in vitro involves distal (07.8/07.0 kb) and proximal (05.4/03.5 kb) enhancer sequences as well as the proximal promoter (00.7//0.1 kb). Transgenic mice carrying an nlacZ reporter gene under the control of different fragments of the upstream region of the cardiac actin gene were generated. This analysis led to the conclusions that (1) the proximal promoter is a weak but tissue specific element in vivo, (2) consistent high-level expression in skeletal muscle depends on the presence of at least one of the enhancers, (3) expression in adult cardiac muscle requires a cardiac enhancer located in the (05.4/00.7 kb) region, and (4) a construct containing these three elements gives a strong specific expression of the transgene in the heart throughout the life of the animal and in embryonic skeletal muscle. All transgenes tested reproduce the down-regulation observed in adult skeletal muscle for the cardiac actin gene. Nonuniform expression of these transgenes in the heart may mark cardiomyocytes derived from different cardiac progenitors. ᭧
INTRODUCTION
. Although many of the proteins expressed on differentiation are the same, skeletal and cardiac Muscle tissues can be divided into two groups, smooth myogenesis differ in a number of important respects. During and striated muscle; the latter group comprising skeletal embryogenesis, the two tissues have a different mesodermal and cardiac muscle. These tissues express actins, myosin origin: skeletal muscle derives from paraxial and the heart light and heavy chains, and other components of the confrom lateral mesoderm (see Kaufman, 1992) . In mouse emtractile apparatus. Most of these proteins exist as different bryos, the first muscle markers are detectable in the cardiac isoforms which are encoded by different genes or result from tube from about 7.5 days post coitum (p.c.) (Sassoon et al., alternative splicing; one isoform usually predominates in a 1988; Lyons et al., 1990; Edmondson et al., 1994) . Subseparticular type of muscle, for instance, skeletal actin is the quently, the tube turns and, after a few days, septation is main isoform in adult skeletal muscle, as cardiac actin is completed. During this period, expression of myosin genes, in the heart. However, very few genes are strictly restricted for example, begins to be restricted to atria or ventricles to one type of striated muscle throughout the life of the (Lyons et al., 1990) . In comparison with the heart, skeletal animal; for example, cardiac and skeletal actins are coexmyogenesis is initiated rather later. Somites, which give pressed in embryonic cardiac and skeletal muscle (see Lyons rise to myogenic precursors, appear from 8 days p.c. and the myotome, the first skeletal muscle mass to form in the trunk of the embryo, expresses muscle markers from 8.5
ate from about 11.5 days p.c. (Ontell et al., 1993) . Undiffer- (Lyons et al., 1991) and decline together in the latter when it matures (Vandekerckhove et al., 1986) . entiated skeletal muscle myoblasts (satellite cells) continue
The proximal promoter of the cardiac actin gene directs to be present in mature muscle which retains the potential expression of a reporter gene in cultured muscle cells, in to regenerate (Ontell, 1975) , whereas in the heart this is not both cardiomyocytes and skeletal myotubes when they difthe case. In contrast to skeletal myoblasts, cardiomyocytes ferentiate from myoblasts. Transcriptional activation in difdo not fuse into fibers, and mononucleated differentiated ferentiating skeletal muscle cells depends critically on an cells can divide in the embryo (see Litvin et al., 1992) . The SP1 site, a CArG-box binding SRF, and an E-box binding two tissues also differ significantly at the molecular level members of the MyoD family (Sartorelli et al., 1990) . The in their content of transcriptional regulatory proteins. In same sites are implicated in cardiomyocytes, although the skeletal muscle, the MyoD family of helix-loop-helix proimportance of the E-box is controversial (Sartorelli et al., teins regulates the transcription of many muscle-specific 1992, Skerjanc and McBurney, 1994) . Analysis of the phenogenes (see Weintraub et al., 1991) . Mutation of these genes type of the BALB/C mouse, in which cardiac actin transcripin the mouse has demonstrated the importance of myogenin tion is perturbed in both skeletal and cardiac muscle (Garfor muscle cell differentiation and of MyoD and myf5 for ner et al., 1986, 1989) , led to the isolation of two musclethe precursor myoblast populations (see Buckingham, specific enhancers at 07.0 and 05.0 kilobases (kb) from the 1994). This family of transcription factors is not present in transcription start site of the gene (Biben et al., 1994) . In the heart, nor in smooth muscle, at any stage of developcultures of differentiating skeletal muscle cells each enment. Conversely, some cardiac transcription factors are hancer increases the activity of a heterologous or a homolonot expressed in skeletal muscle. An example is provided gous promoter by at least 60-fold. Molecular analysis of the by GATA-4, which is specifically present in the myocardistal enhancer (Biben et al., 1994) has demonstrated that dium and in some endothelial tissues (Arceci et al., 1993;  its function depends on an E-box binding the MyoD family Grépin et al., 1994) , and has been shown to be required for of proteins and on a second site recognized by a complex the transcription of a number of cardiac genes (see Gré pin containing Oct1 (B. Kirschbaum and C. Biben, unpublished et al., 1995) . Another example is provided by the homeobox results). The role of these enhancers in cardiomyocytes is protein Nkx2-5 (Lints et al., 1993) , also called CSX (Komuro unknown . In order to test their activities in cardiac and and Izumo, 1993), a mammalian homologue of the tinman skeletal muscle in vivo we carried out transgenic experigene, which is essential for heart formation in Drosophila ments where transcription of an nlacZ (nuclear targeted b- (Bodmer, 1993) . Inactivation of Nkx2-5 in mice does not galactosidase) reporter gene was under the control of differprevent heart formation but interferes with ventricular deent fragments of the upstream region of the mouse cardiac velopment and morphogenesis (Lyons et al., 1995) . Other actin gene. The results obtained lead to the conclusion that factors which play an important role in the regulation of the transcription of this gene is under the control of at least muscle-specific genes are common to both types of striated three elements: a weak but muscle-specific proximal promuscle. This is the case for the MEF2 or RSRF (Related moter, a distal enhancer which functions in embryonic skelSerum Response Factor) family (see Martin et al., 1994; Ed- etal muscle, and a second more proximal enhancer essential mondson et al., 1994) . In Drosophila, mutation of the for expression in the adult heart. unique MEF2 gene (D-MEF2) abolishes differentiation of cardiac, skeletal, and visceral muscles, showing that in the fly, the myogenic program has a key regulator in common MATERIAL AND METHODS (Lilly et al., 1995) .
The cardiac actin gene is expressed in skeletal and cardiac
Construction of Transgenes
muscles of the mouse as soon as they differentiate. Tran-
The first intron of the murine cardiac actin gene was cloned by scripts are detected in the 7.8-day-p.c. mouse embryo in the PCR (Polymerase Chain Reaction) using oligonucleotides compleearly myocardium and in somites from 8.5 days p.c. as the mentary to the 5 end of the first intron and the second exon (undermyotome begins to form (Sassoon et al., 1988) . After birth lined regions): intron 1: 5-GAATTCAGATCTGGATCCCACthe gene is down-regulated in skeletal muscle but tran-ACTCTTAGTTTTG-3 and exon 2: 5-CTTCGAATTCAGATCscripts are still detectable, representing 5% of the total mus-TCCATGGTGGTCTCCTCGTCGTCACA-3 as primers and the cle actin mRNAs (Garner et al., 1989) . Expression remains original l IG10 phage as a template (Garner et al., 1986 (Cox and Buckingham, 1992) . There is no murine cardiac actin gene was inserted into the 5 BamHI site of bridization at 65ЊC in 50 mM Na2HPO4 (pH 7.6), 51 SSC, 51 Denhardt, 0.1% SDS, 100 mg/ml salmon sperm DNA. Filters were pAC1SDKnlacZ1 generating pAC2.4nlacZ.
The T1 transgene was generated by inserting the XbaI-BamHI washed in 0.11 SSC, 0.1% SDS at 65ЊC. Probes (recognizing the bgalactosidase sequence or 5 regions of the cardiac actin gene) were fragment of POX (Biben et al., 1994) containing the 00.66//0.119-kb promoter fragment into pAC2.4nlacZ digested with BamHI and labeled using the Amersham megaprime RPN 1606 random priming kit and purified on a nuctrap push-column (Stratagene). XbaI (partial) in place of the 02.3//0.119-kb fragment. The same strategy was used for cloning the T2 transgene by inserting the Most transgenic lines contained a few copies of the transgene (1 -5). However, certain lines (e.g., T4-296) had much higher copy XbaI-BamHI fragment of 1P (containing the distal enhancer (08.1/ 05.6 kb) juxtaposed to the (00.66//0.1 kb) proximal promoter) numbers ( §50) and b-galactosidase levels were correspondingly higher in these lines. (Biben et al., 1994) into pAC2.4nlacZ.
To generate the T4 transgene, the (09.0/0.66 kb) BamHI-EcoRI fragment of the cardiac actin promoter was cloned from the original
Analysis of the Transgene Expression
(l 5) phage (Biben et al., 1994) as follows: the (05.4/00.66 kb) BamHI-EcoRI fragment was first subcloned into Bluescript (StraMatings. b-Galactosidase expression was assayed in embryos tagene) (pLEB) and the (09.0/05.4 kb) BamHI fragment was inserted and older mice from crosses between F1 transgenic males and into pLEB to generate pLEBB. To generate pAC9nlacZ, the T4 (C57BL/6J 1 CBA) F1 females. Noon of the day of the plug was transgene, a three-part ligation was carried out using pLEBB diconsidered 0.5 days post coitum (d.p.c.). Transgenic embryos were gested with XhoI/EcoRI (09.0/00.66 kb), pAC2.4nlacZ digested identified from wild type by PCR analysis on DNA extracted, as with BamHI/XhoI, and pIG41 digested with EcoRI/BamHI (00.66/ described for the tails, from a small portion of the embryo after /0.119). This strategy was adopted to include the additional EcoRI staining. At later stages DNA was prepared from tail biopsies. site present in the promoter of the cardiac actin gene in C3H mice
Fixation and X-Gal staining. Embryos were dissected in PBS1X (see Biben et al., 1994) . The T3 transgene was generated by a partial and fixed in 4% paraformaldehyde at room temperature for 10-20 BamHI digestion to eliminate the 09. 
Construction of Transgenic Lines
of the tissue. Purification of the injected fragments. Transgenes were linearFixed embryos were washed three times in PBS1X and incubated ized with XhoI and SacII for T1, T2, and T4 and with HindIII for overnight at 32ЊC in 4 mM potassium ferricyanide, 4 mM potassium T3. They were electroeluted from an agarose gel and subsequently ferrocyanide, 2 mM magnesium chloride, 0.4 mg/ml X-Gal, 0.02% purified on an Elutip-d column (Cera-Labo). DNA was then precipi-NP-40 in PBS1X (Sanes et al., 1986) . Isolated adult hearts from T3 tated with ethanol, rinsed, and resuspended in Brinster buffer (see and T4 transgenic lines were stained for 2 hr. In some cases where Hogan et al., 1986) . DNA concentrations were estimated on gels multiple copies of the transgene were present, shorter incubation and fragments diluted to 500 copies/picoliter. times were used for embryos and isolated hearts. Transgenic emInjection procedure. The protocol used was as described in Hobryos and individual muscles were analyzed by whole mount migan et al. (1986) , with the exception that (C57BL/6J 1 SJL) F1 mice croscopy. were used to provide oocytes. Embryos were reimplanted into pseudo-pregnant (C57BL/6J 1 CBA) F1 foster mothers.
RESULTS

Screening of the Transgenic Mice Construction of the Transgenes
Genomic DNA preparation (based on Laird et al., 1991). A 0.5-to 1.0-cm tail biopsy was digested in 0.5 ml of lysis buffer (100 All the transgenes (see Fig. 1 ) encode the Escherichia coli mM TrisrHCl, pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 200 b-galactosidase enzyme targeted to the nucleus by the fumg/ml Proteinase K) overnight at 55ЊC. After 10 min centrifugation sion of a nuclear localization signal (n) (Kalderon et al., (13,000 rpm) , the supernatant was poured into 500 ml of isopropa-1984), which facilitates the detection of specific versus nonnol. The precipitate that formed on shaking was collected with a specific lacZ expression at the cellular level. The basal conyellow Gilson tip and washed in 80% ethanol for 1 min, centristruction is T1 which contains the nlacZ transgene fused fuged, dessicated, and resuspended in 100 ml H2O for 1 hr at 40ЊC.
to the translational initiation codon ATG present in the Polymerase chain reaction. A 260-bp fragment of the b-galactosidase N-terminal sequence was amplified using the following second exon of the mouse cardiac actin gene. Transcription primers (O1: 5-GTCGTTTTACAACGTCGTGACT-3, O2: 5-of this chimeric gene is under the control of the proximal GATGGGCGCATCGTAACCGTGCA-3). One microliter of a promoter (00.66 kb) of the cardiac actin gene. This promoter one-fifth dilution of the above DNA preparation was incubated fragment was used as the reference construct in most of the with 100 ng of each primer in 10 ml for 5 min at 94ЊC. Ten microlitransfection experiments described in Biben et al. (1994) . mologous promoter by about 60-fold. This sequence (E D ) of 1-10. Exceptions are indicated in the description of each type of transgene which follows. Integration effects, which also enhances muscle-specific transcription of the thymidine kinase (TK) gene promoter in differentiated muscle also lead to variation in the absolute levels of expression in striated muscle and to ectopic expression, are also discells (190) (Biben et al., 1994) . The T3 transgene contains a (05.4//0.8 kb) fragment, including the proximal enhancer cussed. (05.4/03.5 kb) which acts as an enhancer increasing the level of muscle-specific transcription from the TK promoter
The Proximal Promoter Is Weak but Specific in
by a factor of 60 (Biben et al., 1994) . T4 is the largest conVivo struct with both enhancers and all the sequences contained from 09.0 to /0.8 kb in the mouse cardiac actin gene.
Of the seven T1 lines in which transgene expression is under the control of the proximal promoter, only two gave Analyses of transgene expression were carried out with established mouse lines (heterozygote (C57BL/6J 1 SJL) F1 a detectable b-galactosidase activity. In both lines skeletal muscle expresses the transgene during embryogenesis ( 
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pression initially in the embryonic heart, the other having galactosidase activity in embryonic skeletal muscle (Fig.  2B ). However, in these lines the heart contains only a few a more ''patchy'' expression pattern. However in both cases expression begins when expected, as soon as the cardiogenic blue nuclei mainly located in the atria and between the ventricles (Fig. 2D ) and this is true in the embryo as well plates differentiate (result not shown). By 10.5 days p.c. in the line with a higher level of expression in the heart, bas in the adult mouse. This is in contrast to the two T1 expressing lines. Since copy numbers were comparable (2-galactosidase labeling is already weaker in the outflow tract ( Fig. 2A) . In both lines the dorsal aorta ( Fig. 2A) is also 10), we conclude that the distal enhancer, unlike the putative enhancer elements at the site of integration of the T1 labeled; this reflects the pattern of expression of the endogenous gene as described by in situ hybridisation (Sassoon et transgene, does not increase the activity of the cardiac actin promoter in the embryonic heart; in addition, it buffers the al., 1988). In the adult heart only occasional blue nuclei are detectable, located in the innermost part of the myocardium proximal promoter against such context effects (see Discussion). Expression in adult skeletal muscle is again restricted (Fig. 2C) .
Since five of seven lines do not express the transgene the to a few fibers (see later). In most of the mice as well as in two sterile founder mice, there is expression in some blood proximal promoter can be considered as a weak transcriptional element. In the two expressing lines, some sites of vessels, in coronary arteries and blood vessels in the lung (results not shown). This does not correspond to a systemectopic expression were noted. While some of these were not common to both lines and are therefore probably due atic expression in smooth muscle since many vessels are not labeled. This pattern of expression was not observed to integration site effects on the weak promoter, a position independent staining in the trigeminal and facial-accoustic with the T1 mice and is presumably due to elements present in the distal enhancer. ganglia detectable from 9.5 days p.c. was observed with all constructs (T1 to T4) in expressing lines (see Fig. 3A ). We
These results show that the distal enhancer is a dominant element since most of the lines express the transgene in a conclude that this is due to sequences present within the proximal promoter.
reproducible way. It is active in skeletal muscle in vivo, but does not drive a detectable level of expression in the vast In the case of the two expressing lines, which had a similar copy number to those of nonexpressing lines, we assume majority of cardiac cells. that the ability of the proximal promoter to direct transcription is enhanced as a consequence of sequences surrounding A Cardiac Enhancer Located between 05.4 and the integration site; it is active in the tissues where the
kb Is Required for High-Level Expression in
endogenous gene is expressed, in a regulated fashion in the the Heart embryo. Expression in the adult mouse is much weaker in both cardiac and skeletal muscle. Whereas in skeletal musSeven of the 11 transgenic lines carrying T3 in which transgene expression is under the control of the proximal cle this was expected based on the activity of the endogenous gene, this result indicates that maintenance of tranpromoter and an additional 05.4 kb of upstream sequence have extensive b-galactosidase staining in skeletal muscle, scription in the heart requires additional elements.
in keeping with the presence of a muscle-specific enhancer, the proximal enhancer (Fig. 3A) . Again, this shows down-
The Distal Enhancer Is Active in Skeletal but Not regulation in the adult (result not shown). The myocardium
Cardiac Muscle in Vivo
is now strongly labeled in the embryo and also in the adult for 6 of these lines (Figs. 3B and 3C) . No staining was obOf the five lines containing the T2 transgene where expression is under the control of the proximal promoter and served in blood vessels, but the blood of 3 of these 6 lines shows expression of the nlacZ transgene in the embryo bethe distal enhancer element, four have high levels of b- In the adult soleus a slow skeletal muscle, no b-galactosidase staining of fibers is seen, except for very rare weakly labeled nuclei indicated by the arrow. (E) In the adult diaphragm, fibers are also negative. (F) In the adult EDL, at lower magnification than C, the overall staining is weak compared with G, which shows an equivalent field from the adult EDL of a transgenic mouse (3F-nlacZ-E) in which the same reporter gene is controlled by regulatory sequences from a fast myosin light chain gene (Kelly et al., 1995) . tween 8.0 and 12.5 days p.c., probably in red blood cells DISCUSSION since these become enucleated with consequent loss of any nuclear targeted lacZ transgene, at about the time when b-
The transgenic experiments reported here show that the galactosidase labeling begins to decrease in the blood. Interexpression of the mouse cardiac actin gene in vivo is under estingly, the staining in the heart tends to be asymmetrical the control of at least three elements: a weak, but specific (see next section).
proximal promoter showing some expression in embryonic We conclude that a regulatory element present in T3, but cardiac and skeletal muscle, and two upstream enhancer not in T1 or T2, stimulates transcription and is required for sequences, the distal enhancer which functions in embryexpression in the adult heart. onic skeletal muscle and a proximal enhancer essential for expression in the adult heart.
The 09.0 to /0.
8-kb Region Is Sufficient for Regulated Position-Independent nlacZ Expression The Proximal Promoter in Cardiac and Skeletal Muscle
Six of six lines express the T4 transgene, which contains Only two of seven transgenic lines express the T1 transgene, and these two lines show sites of ectopic expres-09.0 kb of upstream flanking sequence, in cardiac and skeletal muscle in the embryo (Fig. 4A) , with the expected early sion in addition to expression in striated muscle, indicating that the promoter is weak and subject to position effects. All onset of expression. These lines also show high level expression in the adult heart and down-regulation in adult skeletal expressing lines, with or without the upstream enhancers, show b-galactosidase activity in the trigeminal and facialmuscle, as expected from the expression pattern of the endogenous gene. Of the six T4 lines, one had a higher copy accoustic ganglia. There is no evidence that the endogenous gene is expressed here (Sassoon et al., 1988; , number (ú50 copies of the transgene), and striated muscle stained intensely blue with standard b-galactosidase incu-1991), although a low level of transcription may have been missed, and it is more probable that in the transgenic conbation times. However, when these were reduced, the relative differences between adult and embryonic skeletal musstructions a regulatory element is unmasked in the proximal promoter which directs expression to these sites. The cle were revealed. In adult skeletal muscle of the T4 lines, as with the other transgenes (T1-T3), the tissue is much proximal promoter clearly contains regulatory elements required for activation of the gene in skeletal muscle during less strongly labeled than in the embryo or neonate. The adult extensor digitalis longus (EDL), a fast muscle, shows embryogenesis. Similarly, the proximal promoter of the cardiac actin gene in Xenopus has been demonstrated to cononly very weak staining (Fig. 4F) , compared with limb muscle from a 12.5-d.p.c. T4 transgenic embryo (Fig. 4B) or adult tain the necessary regulatory elements for activation in skeletal muscle cells after mesoderm induction (Mohun et EDL under similar staining conditions and at an equivalent magnification from a transgenic mouse (3F-nlacZ-E; Kelly al., 1986) . In adult skeletal muscle in the mouse, the T1 transgene is down-regulated, reflecting the expression of the et al., 1995) where the nlacZ reporter is under the control of regulatory sequences from a fast myosin light chain gene endogenous gene (Garner et al., 1989) . As in the case of the other cardiac actin transgene constructions, residual expres- (Fig. 4G) . At higher magnification, a subset of fibers in the adult EDL of T4 transgenic mice shows b-galactosidase sion is particularly low in the soleus muscle and the diaphragm where only some fibers are weakly labeled. In fast staining in nuclei (Fig. 4C ). In the adult soleus, a slow muscle, and in the diaphragm, fibers appear b-gal negative (Figs. muscles labeling is more easily detectable, with a regional distribution suggesting overall reduced expression but 4D and 4E); only very occasional blue nuclei can be detected (e.g., Fig. 4D ). maintenance in some fiber types. Since the adult mouse soleus muscle is mainly composed of type I and IIA fibers Transgene expression tends to be asymmetrical in the adult heart and this was the case for both the T3 and T4 (Lewis et al., 1982) and the diaphragm of type I and IIX (Zardini and Parry, 1994) , whereas the fast muscles examtransgenics (Figs. 5A and 5B). Figure 5B shows a striking example of this where the right ventricle is unlabeled. In ined contain mainly IIB fibers, this suggests that IIB fibers continue to express low levels of the transgene. The occaaddition, where the atria are concerned, asymmetry is sometimes detected, with lower labeling in the left atrium (Fig. sional labeled fibers in the soleus muscle and diaphragm may be type IIA or IIX; alternatively, they may be rare IIB 5B). In lines which show asymmetry, the phenomenon is detectable in the embryonic heart before the onset of septafibers which had been missed in these mouse tissues in previous reports. The transgene, therefore, is down-regution (Fig. 5C) . No labeling of blood cells was seen with the T4 transgene, but some blood vessels are labeled as observed lated in all fiber types, but the residual expression is somewhat higher in fast fibers, probably more markedly in IIB with the T2 construct (results not shown).
The fact that T4 containing lines express the transgene type fibers. The contrary might have been expected since a number of genes expressed in the heart are specifically in a reproducible and regulated fashion shows that this construct has a dominant, position-independent activity, reexpressed in adult slow skeletal muscle fibers (see Buckingham, 1990) . It is unlikely that transgene expression in fast sulting in an expression pattern similar to that of the endogenous gene.
IIB fibers is due to the lacZ reporter; transgenic mice with a lacZ reporter gene under the control of the Pgk-1 promoter have b-galactosidase activity in skeletal muscle, but not in type IIB fibers . No information is available on the residual activity of the endogenous cardiac actin gene in different fiber types. This is of the order of 3% of total a-actin (cardiac and skeletal) transcription as detected by Northern analysis (Garner et al., 1989) ; such low levels make this difficult to examine by in situ techniques. In contrast, detection of b-galactosidase activity is extremely sensitive, and furthermore, the nuclear localization sequence concentrates the signal in the nucleus. The proximal promoter can also direct transgene expression to the early embryonic heart, where b-galactosidase activity is more or less extensive depending probably on the enhancer properties of adjacent sequences at the site of integration of the transgene, since copy numbers are similar. However the myocardium is not labeled in the adult, clearly indicating that additional regulatory elements are necessary for expression in the adult heart.
A recent paper (Dunwoodie et al., 1994) describing transgenic experiments using either CAT or the human cardiac actin gene sequence as a reporter, under the control of flanking sequences from the human cardiac actin gene, reports rather different results. The majority of the lines (32 of 41) expressed the transgene and expression remained high in the adult heart. Although the overall level of expression in striated muscle was lower than with 5.7 kb of 5 flanking sequence, this was also seen with an 800-bp promoter fragment. The human and mouse promoter sequences are very similar in the proximal (0485 bp) region (Minty and Kedes, 1986) , and levels of activity in transfection assays with the mouse C2 muscle cell line are also comparable (Daubas et al., 1988; Minty and Kedes, 1986) . The cardiac actin promoter in cultured muscle cells, like the myosin MLC3F promoter (Kelly et al., 1995) , requires enhancer elements to reach high levels of activity (Biben et al., 1994) . The activity of the mouse cardiac actin promoter in cardiac cell cultures has not yet been examined but the human promoter is active both in primary cultures from fetal rat hearts (Sartorelli al., 1992) and in cardiocytes derived from the embryonal 1976), a derivative of primary cultures of ventricular cardiocytes. carcinoma P19 cell line (Skerjanc and McBurney, 1994) , although in both cases the heart cells do not have an adult
The distal enhancer is probably also active in some vascular smooth muscle cells, since expression in blood vessels phenotype. One possible explanation for the lack of expression of the mouse transgenes in the adult heart is the presis clearly seen with the T4 and T2 transgenes, but not the T1 and T3 constructs. Although some of the human cardiac ence of an additional GATA binding site at 0332/0341 in the human cardiac actin promoter (see Molkentin et al., actin transgenic mice also express the transgene in some blood vessels, expression of the endogenous gene has not 1994), absent from the mouse promoter. GATA-4 has been shown to regulate cardiac-specific expression of a myosin been reported in vascular tissue. This may have gone undetected since the coronary vessels which express the nlacZ heavy chain (Molkentin et al., 1994) , cardiac troponin C (Ip et al., 1994) , and atrial natriuretic factor (ANF) (Gré pin et transgene strongly are surrounded by myocardium which expresses high levels of the endogenous gene. Expression al., 1994) genes, and this site may be critical for the level of expression of the cardiac actin transgene. Skeletal muscle elsewhere is detected in a subset of vessels which could have been missed by in situ hybridization, particularly if regulation of the human cardiac actin transgene is also different in the adult. No down-regulation is seen with the transcription is low. The presence of cardiac actin in the vasculature of the lung would not be altogether unexpected proximal promoter fragment of the human gene, whereas this is observed when a 3 flanking sequence is present in since this tissue, the so-called pulmonary myocardium, has been shown to express a number of striated muscle genes, the transgene (Dunwoodie et al., 1994) . This sequence (/6.2//7.3 kb) has a clear effect on mRNA accumulation notably genes also transcribed in the adult atria (Jones et al., 1994) . However, given the lack of activity of the distal and, as the authors suggest, may act via a posttranscriptional mechanism. Transcriptional run-on experiments enhancer in the heart, it is unlikely that the same regulatory element is involved. The question of smooth versus striated with nuclei prepared from fetal and neonatal skeletal muscle tissues suggest that cardiac actin transcription, relative muscle regulation is interesting in the context of the evolution of different a-actin genes from a common ancestor to that of skeletal actin, is lower after birth (Cox and Buckingham, 1992) . The results presented here demonstrate that, (Vandekerckhove and Weber, 1984) . It is quite possible that the a-cardiac actin gene shares a regulatory element in the at least for the mouse gene, there is a transcriptional level of control, mediated via the proximal promoter. We can distal enhancer with the a-smooth actin gene, and that in the mouse a-cardiac actin locus this element is normally exclude the possibility that the nlacZ reporter gene sequence is responsible, since a similar reporter gene shows masked. high-level expression in adult skeletal muscle with myosin (Kelly et al., 1995) regulatory elements. These apparent difThe Cardiac Muscle Enhancer, Alone and in ferences between the human and mouse cardiac actin genes Conjunction with the Distal Enhancer may be partly due to the fact that several regulatory mechanisms are operating together, but they also underscore the Comparison of T3 and T1 mice shows that the T3 construct contains an element which will reproducibly direct potential importance of species-specific regulation of gene expression; such divergence is particularly striking in the transcription of the proximal promoter in skeletal and cardiac muscle cells in the embryo. Experiments in cell culture case of such a highly conserved sequence as cardiac actin.
had already shown that an element lying between 05.4 and 03.5 kb enhances expression of the proximal promoter in differentiated skeletal muscle cells (Biben et al., 1994) . The
The Distal Skeletal Muscle Enhancer
fact that a number of lines (5/11) do not express the transgene suggests that this proximal enhancer is more subMost of the mice carrying the T2 transgene have b-galactosidase activity in embryonic skeletal muscle (four indeject to integration site effects than the distal element. Indeed, when the distal enhancer is also present in the T4 pendent integration sites of five, see table in Fig. 1) . When compared to the score with the T1 transgene, it is clear that transgene, 6/6 lines express nlacZ in embryonic skeletal and cardiac muscle and in the adult heart, reproducing the the presence of the distal enhancer is sufficient to activate transcription of the proximal promoter in skeletal muscle.
expression of the endogenous gene. The distal enhancer relieves position-dependent constraints and in this sense acts However, very little labeling is seen in the embryonic heart and virtually none in the adult. The absence of activity in as a locus control region element. Unlike the distal enhancer in T2 mice, sequences in the T3 transgene also direct the heart shows that the enhancer is inactive in the myocardium, except perhaps in rare cell lineages. The result is b-galactosidase activity throughout the embryonic heart, and this is maintained in the adult. The possibility that the consistent with observations on cultured muscle cells which showed that activity of the distal enhancer depends distal enhancer may function as a cardiac silencing element, at least in the embryo, arises because the two expressing on an E-box which binds myogenic factors of the MyoD family (Biben et al., 1994) absent in cardiac cells (see Buck- lines which contain only the proximal promoter show bgalactosidase staining in the embryonic heart. However the ingham, 1994) and that it is inactive (C. Biben, unpublished observations) in the H9 rat cell line (Kimes and Brandt, T4 transgene which contains the distal enhancer consis-tently expresses throughout the heart, and furthermore bis therefore unlikely to reflect a physiological response of the different chambers of the heart to different haemodygalactosidase staining in the adult heart is only seen in T3 and T4 lines, leading to the conclusion that a positive carnamic loads. These transgenic mice may therefore provide a useful tool for examining the origin of cells which popudiac regulatory element is present in these transgenes. Whether it is the proximal enhancer itself which is responlate the left and right ventricles. Indeed in cases where the transgene is only expressed in a few patchy locations in the sible is under investigation.
Interestingly T3, but not T4 mice have an ectopic nlacZ embryonic heart (e.g., Fig. 2 with T1 or T2) the potentially distinct clonal origin of these myocardial cells can also now expression in blood cells. The GATA-4 transcription factor has been shown to regulate gene expression in the heart be explored. (e.g., Gré pin et al., 1994) , whereas other members of the GATA family are potent regulators of hematopoiesis. It re-
Regulation of Genes in Cardiac versus Skeletal
mains to be shown whether the cardiac enhancer is reguMuscle lated via a GATA site, if this is the case it is possible that in the T3 transgene, unlike the endogenous gene or the T4
For genes expressed in both striated muscle types, there is already some indication that distinct cardiac and skeletal transgene, this site is more accessible to transactivation by other members of the GATA family.
regulatory elements may be active in vivo. The mouse Mphosphocreatine kinase gene is regulated by a complex set of cis-acting sequences (Johnson et al., 1989) including an Left/Right Transcriptional Heterogeneity in the upstream region located between 03300 and 01256 bp from Heart the cap site, which appears to be implicated in the enhancement of cardiac rather than skeletal muscle expression, and Although the proximal enhancer directs transgene expression to the adult heart, b-galactosidase staining is nonunian intronic enhancer which activates expression in skeletal, but not cardiac muscle. The MCK enhancer present beform; the right ventricle is always less labeled than the left with the T3 and T4 constructs. Reverse transcriptase tween 01256 and 01049 bp which has been the subject of many in vitro studies increases CAT reporter gene activity, polymerase chain reactions with RNA samples from the right and left atria and ventricles indicate that the gene is in transgenic mice, in both types of striated muscle. However, in DNA injection experiments, the equivalent enevenly expressed in the myocardium (S. Alonso, personal communication), as do in situ hybridization experiments hancer from the rabbit MCK gene was inactive in the heart, whereas it enhanced expression of the CAT reporter gene (see Garner et al., 1989) . The phenomenon is not only seen in the adult heart and is already detectable in the embryo.
in skeletal muscle (Vincent et al., 1993) . An extensive transgenic analysis of a human gene encoding another metaIt is also seen with the transgenic line T1 where there is virtually no expression in the adult heart. This would sugbolic enzyme, aldolase A, where expression in skeletal muscle, heart, and nonmuscle tissues is shown to be regulated gest that the regulatory sequences which respond to cardiac signals leading to nonuniform distribution are present in by different promoters, also points to the presence of a distinct skeletal muscle specific enhancer sequence (Conthe T1 construct. The lacZ reporter itself is unlikely to be responsible, since the human myoglobin promoter -lacZ cordet et al., 1993) . In the case of other muscle transgenes it is more by default that one can conclude that distinct transgene does not show this phenomenon (Parsons et al., 1993) in adult mouse hearts. We have, however, obtained a elements must exist. A luciferase reporter gene under the control of 02 kb of upstream sequence from the slow/vensimilar result with a myosin light chain (MLC3F) nlacZ transgene where we have shown that the enzyme activity tricular myosin light chain, MLC2V/S, gene is expressed in the heart, but not in slow skeletal muscle (Lee et al., 1992) , reflects the accumulation of b-galactosidase mRNA (Kelly et al., 1995) , pointing to a transcriptional regulation. Rewhereas 1 kb of 5 flanking sequence from the desmin gene directs expression to skeletal muscle, but not to the heart gional specificity of a slow/ventricular myosin light chain MLC2V/S luciferase transgene has also been reported in the where the endogenous gene is also expressed (Li et al., 1993) . In other transgenic experiments, the sequences used diadult mouse heart with higher expression in the left ventricle (Lee et al., 1992) . We have not yet investigated more rected expression to both types of striated muscle in vivo (e.g., myoglobin, Parsons et al., 1993) . Two classes of tranclosely the sequence element(s) implicated in the left/right modulation of the cardiac actin transgene. Either additional scription factors important in one and not the other striated muscle type are clearly identified at present, namely, the sequences, necessary for right ventricular expression, are missing from the transgene or sequences present in the MyoD family in skeletal muscle (Weintraub et al., 1991) and the GATA-4 factor in cardiac muscle (e.g., Gré pin et transgene which respond to differences in left/right regulatory signals are masked in the endogenous gene. The pheal., 1994) . Injection of GATA-4 into the skeletal muscle of the tongue will induce expression of a cardiac a-myosin nomenon itself is also of potential interest in the context of lineage analysis in the early heart. Although it is difficult heavy chain gene construct (Molkentin et al., 1994) and conversely expression of MyoD in the heart of transgenic to exclude the influence of possible early differences in local environment, the nonuniform distribution is clearly seen mice induced some skeletal muscle gene expression (Miner et al., 1992) . From the results reported here and those diswell before cardiac septation is complete in the embryo and of the myosin alkali light chain gene in primary muscle cell cussed, it is clear that distinct cardiac and skeletal regula- actin gene, of a weak striated muscle promoter which is Dunwoodie, S. L., Joya, J. E., Arkell, R. M., and Hardeman, E. C. activated by cardiac and skeletal upstream enhancer se- (1994) . Multiple regions of the human cardiac actin gene are necquences provides a model for the regulation of a gene exessary for maturation-based expression in striated muscle. J. Biol. pressed in both striated muscles. In the context of biomediChem. 269, 12212 -12219. cal applications, the in vivo definition of such skeletal or Garner, I., Minty, A. J., Alonso, S., Barton, P. J., and Buckingham, cardiac specific enhancer elements is of potential impor- M. E. (1986) . A 5 duplication of the a-cardiac actin gene in BALB/ tance, for example, in targeting expression of a sequence to c mice is associated with abnormal levels of a-cardiac and athe adult heart. skeletal actin mRNAs in adult cardiac tissue. EMBO J. 5, 2559 -2567. Garner, I., Sassoon, D., Vandekerckhove, J., Alonso, S., and Buckingham, M. E. (1989) . A developmental study of the abnormal
